Colorectal cancer risk up for patients with psoriasis
Nov 30, 2021
In subgroup analysis according to sex, increased risk for CRC seen for female, but not male psoriasis patients
Nursing home resident dies after allegedly being smothered by son
By
Stephanie H. Kim
Jul 31, 2014
A terminally ill nursing home resident in Ohio has died after his son is alleged to have smothered him, according to police.
Common measure of mortality also predicts cancer survival in seniors
By
Alicia Lasek (f3)
May 09, 2022
The Charlson Comorbidity Index accurately predicts morbidity in elderly patients with cancer, a new investigation has found.
FDA panel approves first biosimilar drug
Mar 10, 2015
The Food and Drug Administration approved its first biosimilar product last week, opening the door for more costly drug alternatives.
Report: Accelerated aging linked to early-onset cancers
By
Kristen Fischer
Apr 18, 2024
People under the age of 55 are more likely to experience accelerated aging, and that’s linked to more early-onset solid tumors, according to research presented at the American Association for Cancer...
Two new drugs show promise for hard-to-treat breast, prostate cancers
By
Alicia Lasek
Jun 07, 2021
Cancer drug Lynparza (olaparib) reduced the risk of disease recurrence or death in certain aggressive breast cancers by 42% after surgery, while a new prostate cancer treatment improved survival by tracking...
Functional limitations more than double over 20 years among U.S. cancer survivors
By
Alicia Lasek
Jun 08, 2023
More lives are being saved from cancer, but the findings underscore the need for greater access to high quality survivorship care, investigators say.
Coffee drinkers have reduced risk of common liver cancer: study
By
Alicia Lasek
Nov 09, 2019
Middle-aged coffee drinkers have half the odds of developing a common liver cancer than their peers who don’t partake, say researchers.
Seniors have fewer chemotherapy side effects with supportive care program, clinical trial finds
By
Alicia Lasek
Oct 01, 2021
Patients in the intervention group experienced a 10% reduction in moderate side effects — without significant chemotherapy modifications or dose reductions, investigators say.